000 01492 a2200385 4500
005 20250514042720.0
264 0 _c20021017
008 200210s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/s00280-002-0490-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShen, Meiyu
245 0 0 _aPopulation pharmacokinetic and limited sampling models for carboplatin administered in high-dose combination regimens with peripheral blood stem cell support.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_cSep 2002
300 _a243-50 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aArea Under Curve
650 0 4 _aCarboplatin
_xadministration & dosage
650 0 4 _aCombined Modality Therapy
650 0 4 _aFemale
650 0 4 _aForecasting
650 0 4 _aHematopoietic Stem Cell Transplantation
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aModels, Theoretical
650 0 4 _aOvarian Neoplasms
_xdrug therapy
700 1 _aSchilder, Russell J
700 1 _aObasaju, Coleman
700 1 _aGallo, James M
773 0 _tCancer chemotherapy and pharmacology
_gvol. 50
_gno. 3
_gp. 243-50
856 4 0 _uhttps://doi.org/10.1007/s00280-002-0490-y
_zAvailable from publisher's website
999 _c12084383
_d12084383